KZR-616 is currently being evaluated in Phase 2 clinical trials for the treatment of lupus nephritis and dermatomyositis/polymyositis. Find out how KZR-616 works to harmonize the immune system.
To learn more about participating in our clinical trials, please email clinicaltrials@kezarbio.com.